Progressive (NYSE:PGR) reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $0.94 by 17.02 percent. This is a 52.78 percent increase over earnings of $0.72 per share from the same period last year. The company reported quarterly sales of $12.15 billion which missed the analyst consensus estimate of $12.46 billion by 2.50 percent. This is a 10.62 percent increase over sales of $10.98 billion the same period last year.
Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer’s, Parkinson’s & Huntington’s Treatment
The study focused on the potential of rare cannabinoids in the treatment of neurodegenerative diseases like Alzheimer's.
According to the researchers behind the study, this breakthrough research opens new avenues for addressing the unmet medical needs of patients with conditions like Alzheimer's, Parkinson's, and Huntington's diseases.
